The pharmaceutical industry in the United States is experiencing a rapid surge in requirement for Tirzepatide APIs. This effective medication, used to treat type 2 diabetes, has captured extensive attention from both patients and healthcare professionals. As a result, numerous firms have emerged as producers of Tirzepatide APIs in the USA. Well-